| Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo … CL Leonardi, AB Kimball, KA Papp, N Yeilding, C Guzzo, Y Wang, S Li, ... The Lancet 371 (9625), 1665-1674, 2008 | 1997 | 2008 |
| Two phase 3 trials of dupilumab versus placebo in atopic dermatitis EL Simpson, T Bieber, E Guttman-Yassky, LA Beck, A Blauvelt, MJ Cork, ... New England Journal of Medicine 375 (24), 2335-2348, 2016 | 1875 | 2016 |
| Adalimumab therapy for moderate to severe psoriasis: a randomized, controlled phase III trial A Menter, SK Tyring, K Gordon, AB Kimball, CL Leonardi, RG Langley, ... Journal of the American Academy of Dermatology 58 (1), 106-115, 2008 | 1100 | 2008 |
| Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe … A Blauvelt, KA Papp, CEM Griffiths, B Randazzo, Y Wasfi, YK Shen, S Li, ... Journal of the american academy of dermatology 76 (3), 405-417, 2017 | 920 | 2017 |
| Phase 3 studies comparing brodalumab with ustekinumab in psoriasis M Lebwohl, B Strober, A Menter, K Gordon, J Weglowska, L Puig, K Papp, ... New England Journal of Medicine 373 (14), 1318-1328, 2015 | 872 | 2015 |
| IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2–dependent mechanisms with implications for psoriasis pathogenesis JR Chan, W Blumenschein, E Murphy, C Diveu, M Wiekowski, ... The Journal of experimental medicine 203 (12), 2577-2587, 2006 | 857 | 2006 |
| Two phase 3 trials of adalimumab for hidradenitis suppurativa AB Kimball, MM Okun, DA Williams, AB Gottlieb, KA Papp, CC Zouboulis, ... New England Journal of Medicine 375 (5), 422-434, 2016 | 706 | 2016 |
| The psychosocial burden of psoriasis AB Kimball, C Jacobson, S Weiss, MG Vreeland, Y Wu American journal of clinical dermatology 6, 383-392, 2005 | 700 | 2005 |
| National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening AB Kimball, D Gladman, JM Gelfand, K Gordon, EJ Horn, NJ Korman, ... Journal of the American Academy of Dermatology 58 (6), 1031-1042, 2008 | 609 | 2008 |
| Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials K Reich, KA Papp, A Blauvelt, SK Tyring, R Sinclair, D Thaçi, K Nograles, ... The Lancet 390 (10091), 276-288, 2017 | 567 | 2017 |
| North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I … A Alikhan, C Sayed, A Alavi, R Alhusayen, A Brassard, C Burkhart, ... Journal of the American Academy of Dermatology 81 (1), 76-90, 2019 | 564 | 2019 |
| Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial AB Kimball, F Kerdel, D Adams, U Mrowietz, JM Gelfand, R Gniadecki, ... Annals of internal medicine 157 (12), 846-855, 2012 | 531 | 2012 |
| Hidradenitis suppurativa R Sabat, GBE Jemec, Ł Matusiak, AB Kimball, E Prens, K Wolk Nature Reviews Disease Primers 6 (1), 18, 2020 | 486 | 2020 |
| The response of skin disease to stress: changes in the severity of acne vulgaris as affected by examination stress A Chiu, SY Chon, AB Kimball Archives of dermatology 139 (7), 897-900, 2003 | 480 | 2003 |
| Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with … PL Mattei, KC Corey, AB Kimball Journal of the European Academy of Dermatology and Venereology 28 (3), 333-337, 2014 | 388 | 2014 |
| Quantifying the harmful effect of psoriasis on health-related quality of life SC Weiss, AB Kimball, DJ Liewehr, A Blauvelt, ML Turner, EJ Emanuel Journal of the American Academy of Dermatology 47 (4), 512-518, 2002 | 387 | 2002 |
| Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity CC Zouboulis, T Tzellos, A Kyrgidis, GBE Jemec, FG Bechara, ... British Journal of Dermatology 177 (5), 1401-1409, 2017 | 381 | 2017 |
| Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials C Ryan, CL Leonardi, JG Krueger, AB Kimball, BE Strober, KB Gordon, ... Jama 306 (8), 864-871, 2011 | 338 | 2011 |
| Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis J Shlyankevich, AJ Chen, GE Kim, AB Kimball Journal of the American Academy of Dermatology 71 (6), 1144-1150, 2014 | 333 | 2014 |
| Text-message reminders to improve sunscreen use: a randomized, controlled trial using electronic monitoring AW Armstrong, AJ Watson, M Makredes, JE Frangos, AB Kimball, ... Archives of dermatology 145 (11), 1230-1236, 2009 | 314 | 2009 |
